Page last updated: 2024-10-30

labetalol and Uterine Inertia

labetalol has been researched along with Uterine Inertia in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Uterine Inertia: Failure of the UTERUS to contract with normal strength, duration, and intervals during childbirth (LABOR, OBSTETRIC). It is also called uterine atony.

Research Excerpts

ExcerptRelevanceReference
"We identified a cohort of 9750 patients with outpatient prescriptions for CCBs, methyldopa, or labetalol for pre-existing or gestational hypertension whose days of supply overlapped with delivery; 1226 were exposed to CCBs."3.79Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study. ( Bateman, BT; Ecker, JL; Fischer, MA; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Palmsten, K; Seely, EW, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bateman, BT1
Hernandez-Diaz, S1
Huybrechts, KF1
Palmsten, K1
Mogun, H1
Ecker, JL1
Seely, EW1
Fischer, MA1

Other Studies

1 other study available for labetalol and Uterine Inertia

ArticleYear
Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.
    BJOG : an international journal of obstetrics and gynaecology, 2013, Volume: 120, Issue:13

    Topics: Adolescent; Adult; Antihypertensive Agents; Calcium Channel Blockers; Cohort Studies; Female; Humans

2013